Ziel
A unique combination of earlier EU funded projects allow four research SME´s to create a combined most visionary and innovative product for improved health. There is a strategic decision from pharmaceutical companies and hospitals for:
1. continues expressing of biologicals to fulfill the expectation to “personalized medicine” and 2. proliferation of cells to support therapeutic applications and 3. proliferation of stem cells to prepare manufacturing of real “human spare
parts”. Advanced process control inside tailor made and cell harboring scaffolds integrated in a High-Efficient-Single-Use-Bioreactor simulating mammalian tissue conditions will fulfill this requirements
Wissenschaftliches Gebiet
Programm/Programme
Aufforderung zur Vorschlagseinreichung
FP7-HEALTH-2013-INNOVATION-2
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
CP-FP - Small or medium-scale focused research projectKoordinator
100 44 Stockholm
Schweden